Not applicableNot Yet RecruitingNCT07735559
What this trial is testing
SAFE-iPS - France's First Hospital-based Platform for the Production of Induced Pluripotent Stem Cells for the Regenerative Medicine of the Future
Who this might be right for
Regenerative MedicineInduced Pluripotent Stem Cells (iPSC) Production
University Hospital, Montpellier 6